APM

Avidity Partners Management Portfolio holdings

AUM $499M
1-Year Est. Return 3.47%
This Quarter Est. Return
1 Year Est. Return
+3.47%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$485M
AUM Growth
-$518M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
82
New
Increased
Reduced
Closed

Top Buys

1
+$13.9M
2
+$10.9M
3
+$10.8M
4
OGN icon
Organon & Co
OGN
+$7.97M
5
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$7.62M

Top Sells

1
+$33.8M
2
+$28.2M
3
+$26.1M
4
DNTH icon
Dianthus Therapeutics
DNTH
+$20.9M
5
KYMR icon
Kymera Therapeutics
KYMR
+$20.1M

Sector Composition

1 Healthcare 98.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LXEO icon
51
Lexeo Therapeutics
LXEO
$601M
$2.24M 0.43%
+645,000
VERA icon
52
Vera Therapeutics
VERA
$1.55B
$2.19M 0.42%
91,000
-9,000
RGNX icon
53
Regenxbio
RGNX
$584M
$1.86M 0.35%
260,000
-272,000
IONS icon
54
Ionis Pharmaceuticals
IONS
$11.8B
$1.81M 0.35%
+60,000
MIRM icon
55
Mirum Pharmaceuticals
MIRM
$3.57B
$1.8M 0.34%
40,000
-626,200
NAMS icon
56
NewAmsterdam Pharma
NAMS
$4.11B
$1.39M 0.27%
68,000
-286,000
AGL icon
57
Agilon Health
AGL
$300M
$1.32M 0.25%
+305,100
SCYX icon
58
SCYNEXIS
SCYX
$26.4M
$1.17M 0.22%
1,228,910
PCVX icon
59
Vaxcyte
PCVX
$5.37B
$868K 0.17%
+23,000
KPTI icon
60
Karyopharm Therapeutics
KPTI
$96.3M
$503K 0.1%
134,566
-1
ELVN icon
61
Enliven Therapeutics
ELVN
$1.13B
$222K 0.04%
+11,300
HYPR icon
62
Hyperfine
HYPR
$98.2M
$159K 0.03%
222,174
-966,004
RVPH icon
63
Reviva Pharmaceuticals
RVPH
$53.3M
$132K 0.03%
+138,000
ABBV icon
64
AbbVie
ABBV
$381B
– –
-80,700
ASND icon
65
Ascendis Pharma
ASND
$12.6B
– –
-62,000
BLUE
66
DELISTED
bluebird bio
BLUE
– –
-81,555
BMY icon
67
Bristol-Myers Squibb
BMY
$92.8B
– –
-215,000
COGT icon
68
Cogent Biosciences
COGT
$1.97B
– –
-287,104
DYN icon
69
Dyne Therapeutics
DYN
$3.06B
– –
-96,000
GMAB icon
70
Genmab
GMAB
$17.7B
– –
0
ILMN icon
71
Illumina
ILMN
$17.9B
– –
-109,700
INCY icon
72
Incyte
INCY
$20.2B
– –
-129,600
ISRG icon
73
Intuitive Surgical
ISRG
$191B
– –
-64,800
KROS icon
74
Keros Therapeutics
KROS
$474M
– –
-210,000
KYMR icon
75
Kymera Therapeutics
KYMR
$4.31B
– –
-500,000
1 2
3
4